These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4342117)

  • 1. Premorbid adjustment, phenothiazine treatment, and remission in acute schizophrenics.
    Evans JR; Rodnick EH; Goldstein MJ; Judd LL
    Arch Gen Psychiatry; 1972 Oct; 27(4):486-90. PubMed ID: 4342117
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenothiazine effects in good premorbid schizophrenics divided into paranoid-nonparanoid status.
    Judd LL; Goldstein MJ; Rodnick EH; Jackson NL
    Arch Gen Psychiatry; 1973 Aug; 29(2):207-21. PubMed ID: 4582360
    [No Abstract]   [Full Text] [Related]  

  • 3. Specific indications for different classes of phenothiazines.
    Hollister LE; Overall JE; Kimbell I; Pokorny A
    Arch Gen Psychiatry; 1974 Jan; 30(1):94-9. PubMed ID: 4148660
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical investigations and computer analysis of EEG effects of thioridazine hydrochloride on chronic schizophrenics.
    Akpinar S; Itil T; Marasa J; Keskiner A
    Psychiatr Clin (Basel); 1972; 5(5):289-99. PubMed ID: 4559602
    [No Abstract]   [Full Text] [Related]  

  • 5. Premorbid adjustment, paranoid diagnosis, and remission. Acute schizophrenics treated in a community mental health center.
    Evans JR; Goldstein MJ; Rodnick EH
    Arch Gen Psychiatry; 1973 May; 28(5):666-72. PubMed ID: 4349538
    [No Abstract]   [Full Text] [Related]  

  • 6. Prediction of response to phenothiazines in schizophrenia. A crossvalidation study.
    Goldberg SC; Frosch WA; Drossman AK; Schooler NR; Johnson GF
    Arch Gen Psychiatry; 1972 Apr; 26(4):367-73. PubMed ID: 4552130
    [No Abstract]   [Full Text] [Related]  

  • 7. Group vs individual psychotherapy with schizophrenics. A controlled outcome study.
    O'Brien CP; Hamm KB; Ray BA; Pierce JF; Luborsky L; Mintz J
    Arch Gen Psychiatry; 1972 Oct; 27(4):474-8. PubMed ID: 4342116
    [No Abstract]   [Full Text] [Related]  

  • 8. Premorbid asocial adjustment and response to phenothiazine treatment among schizophrenic inpatients.
    Klein DF; Rosen B
    Arch Gen Psychiatry; 1973 Oct; 29(4):480-5. PubMed ID: 4583948
    [No Abstract]   [Full Text] [Related]  

  • 9. A double blind comparative trial of pericyazine and thioridazine in chronic schizophrenia.
    Barker JC; Miller M
    Br J Psychiatry; 1969 Feb; 115(519):169-72. PubMed ID: 4888133
    [No Abstract]   [Full Text] [Related]  

  • 10. The aftercare of schizophrenics: an evaluation of group and individual approaches.
    Levene HI; Patterson V; Murphey BG; Overbeck AL; Veach TL
    Psychiatr Q; 1970; 44(2):296-304. PubMed ID: 4318915
    [No Abstract]   [Full Text] [Related]  

  • 11. A controlled study of the effects of gamfexine in phenothiazine-treated patients.
    Zimmermann RL; Vestre ND; Schiele BC; Curran J
    Curr Ther Res Clin Exp; 1970 Apr; 12(4):230-3. PubMed ID: 4985944
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduction in hospitalization of schizophrenics.
    Claghorn JL; Kinross-Wright J
    Am J Psychiatry; 1971 Sep; 128(3):344-7. PubMed ID: 4328320
    [No Abstract]   [Full Text] [Related]  

  • 13. The prevention of hospitalization in schizophrenia: five years after an experimental program.
    Davis AE; Dinitz S; Pasamanick B
    Am J Orthopsychiatry; 1972 Apr; 42(3):375-88. PubMed ID: 4335894
    [No Abstract]   [Full Text] [Related]  

  • 14. A study of thioridazine and its side-chain derivative, mesoridazine, in chronic male hospitalized psychiatric patients.
    Mena A; Grayson H; Cohen S
    J New Drugs; 1966; 6(6):345-8. PubMed ID: 5341416
    [No Abstract]   [Full Text] [Related]  

  • 15. Potentiation of therapeutic effects of nicotinic acid by pyridoxine in chronic schizophrenics.
    Ananth JV; Ban TA; Lehmann HE
    Can Psychiatr Assoc J; 1973 Oct; 18(5):377-83. PubMed ID: 4147710
    [No Abstract]   [Full Text] [Related]  

  • 16. Schizophrenic subtypes defined by response to drugs and placebo.
    Goldberg SC; Mattsson NB
    Dis Nerv Syst; 1968 May; 29(5):Suppl:153-8. PubMed ID: 4876985
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparative trial of haloperidol and thioridazine: management of chronic schizophrenia.
    Weston MJ; Bentley R; Unwin A; Morris M; Harper MA
    Aust N Z J Psychiatry; 1973 Mar; 7(1):52-7. PubMed ID: 4579393
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
    Kiev A; Güclü B; Kulkarni AS
    Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
    [No Abstract]   [Full Text] [Related]  

  • 19. Behavioral effects of drug therapy on psychogeriatric inpatients. I. Chlorpromazine and thioridazine.
    Altman H; Mehta D; Evenson RC; Sletten IW
    J Am Geriatr Soc; 1973 Jun; 21(6):241-8. PubMed ID: 4575803
    [No Abstract]   [Full Text] [Related]  

  • 20. Intensive treatment of the chronic schizophrenic.
    Friedman JJ
    Psychiatr Q; 1967 Jul; 41(3):550-6. PubMed ID: 4294878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.